About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
CNS Drugs
›
top-articles
CNS Drugs
5.6
(top 5%)
impact factor
2.5K
(top 10%)
papers
99.2K
(top 5%)
citations
133
(top 5%)
h
-index
5.8
(top 5%)
impact factor
2.7K
all documents
104.9K
doc citations
190
(top 5%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Second-Generation (Atypical) Antipsychotics and Metabolic Effects
CNS Drugs
2005
921
2
Internet Addiction
CNS Drugs
2008
568
3
Pharmacological and Therapeutic Properties of Valproate
CNS Drugs
2002
561
4
Arterial Stiffness and Stroke in Hypertension
CNS Drugs
2005
559
5
Basic Pharmacology of Valproate
CNS Drugs
2002
556
6
Neuropsychiatric Adverse Effects of Interferon-??
CNS Drugs
2005
422
7
Cognitive Effects of Long-Term Benzodiazepine Use
CNS Drugs
2004
420
8
Intranasal Insulin as a Treatment for Alzheimer’s Disease: A Review of Basic Research and Clinical Evidence
CNS Drugs
2013
402
9
Mechanism of Action of Atypical Antipsychotic Drugs and the Neurobiology of Schizophrenia
CNS Drugs
2006
385
10
Getting into the Brain
CNS Drugs
2009
371
11
The Role of Insulin Resistance in the Pathogenesis of Alzheimer??s Disease
CNS Drugs
2003
366
12
Adverse Effects of Atypical Antipsychotics
CNS Drugs
2007
364
13
Sleep Disturbances in Patients with Schizophrenia
CNS Drugs
2008
360
14
Frontotemporal Lobar Degeneration
CNS Drugs
2010
353
15
Suicidal Behaviour in Bipolar Disorder
CNS Drugs
2003
342
16
Potential Mechanisms of Action of Lithium in Bipolar Disorder
CNS Drugs
2013
337
17
Smoking Cessation in Women
CNS Drugs
2001
335
18
Tianeptine
CNS Drugs
2001
308
19
Crossing the Blood–Brain Barrier: Recent Advances in Drug Delivery to the Brain
CNS Drugs
2017
304
20
Mechanism of Action of St John???s Wort in Depression
CNS Drugs
2003
301
21
Toward a New Understanding of Attention-Deficit Hyperactivity Disorder Pathophysiology
CNS Drugs
2009
300
22
Antiepileptic Drugs in Non-Epilepsy Disorders
CNS Drugs
2008
293
23
Zolpidem
CNS Drugs
2005
289
24
Dopamine Partial Agonists
CNS Drugs
2004
285
25
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
CNS Drugs
2018
284
26
Neurobiological and Clinical Effects of the Antidepressant Tianeptine
CNS Drugs
2008
281
27
Sleep Disturbances in Patients with Post-Traumatic Stress Disorder
CNS Drugs
2006
275
28
??-1 Receptor Ligands
CNS Drugs
2004
266
29
Blonanserin
CNS Drugs
2010
263
30
Benzodiazepines and Risk of Hip Fractures in Older People
CNS Drugs
2003
257
31
The Mechanism of Action of Interferon-β in Relapsing Multiple Sclerosis
CNS Drugs
2011
257
32
The Role of Memantine in the Treatment of Psychiatric Disorders Other Than the Dementias
CNS Drugs
2012
257
33
Withdrawing Benzodiazepines in Primary Care
CNS Drugs
2009
255
34
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis
CNS Drugs
2014
254
35
Effects of Newer Antipsychotics on Extrapyramidal Function
CNS Drugs
2002
251
36
Propofol: A Review of its Role in Pediatric Anesthesia and Sedation
CNS Drugs
2015
251
37
Oxidative Damage and Schizophrenia
CNS Drugs
2001
250
38
Serotonin 5-HT1A Receptors as Targets for Agents to Treat Psychiatric Disorders: Rationale and Current Status of Research
CNS Drugs
2013
245
39
Venlafaxine Extended-Release
CNS Drugs
2001
242
40
A Pooled Analysis of Lacosamide Clinical Trial Data Grouped by Mechanism of Action of Concomitant Antiepileptic Drugs
CNS Drugs
2010
238
41
The Effects of Novel and Newly Approved Antipsychotics on Serum Prolactin Levels: A Comprehensive Review
CNS Drugs
2014
238
42
Psychogenic Excoriation
CNS Drugs
2001
237
43
Residual Effects of Hypnotics
CNS Drugs
2004
237
44
Ramelteon
CNS Drugs
2005
236
45
Sleep Disturbances in Patients with Alzheimer??s Disease
CNS Drugs
2001
231
46
Selectivity of Cholinesterase Inhibition
CNS Drugs
1999
230
47
Antipsychotic-Induced Weight Gain in Chronic and First-Episode Psychotic Disorders
CNS Drugs
2008
229
48
Ziprasidone in the Management of Schizophrenia
CNS Drugs
2003
227
49
Pharmacotherapy of Essential Tremor
CNS Drugs
2008
226
50
The Hippocampus, Neurotrophic Factors and Depression
CNS Drugs
2011
221
site/software ©
exaly
; All materials licenced under
CC by-SA
.